Indehaveren af markedsføringstilladelsen anerkendte, at indikationsafsnittet varierer meget i de forskellige medlemsstater, men at formuleringsforskellene svarer til tre velidentificerede indikationer.
The MAH acknowledged that the indication section varies a lot from one Member State to the other but that the wording differences corresponded to three well-identified indications.